SCHEMBL5386830

SCHEMBL5386830

O=S(=O)(Nc1nc(-c2ccsc2)ns1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP36 Q9P275 2/20 0.55
KDM1A O60341 4/20 0.51
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
ALOX12 P18054 1/20 0.43
MAOA P21397 1/20 0.42
HSD11B1 P28845 1/20 0.42
POLB P06746 1/20 0.42
NPC1 O15118 1/20 0.42
CASP3 P42574 1/20 0.42
RAB9A P51151 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
KAT6A Q92794 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5389758 0.89 PGR (0.45) USP36KDM1AMEN1KMT2AHTT
SCHEMBL5832011 0.88 USP36 (0.67) USP36KDM1AMEN1KMT2AHTT
SCHEMBL5396020 0.86 KDM1A (0.49) KDM1AMEN1KMT2AHTTMAOA
SCHEMBL5405087 0.81 LMNA (0.61) USP36KDM1AMEN1KMT2AHTT
SCHEMBL5832082 0.81 USP36 (0.55) USP36KDM1AMEN1KMT2AHTT
SCHEMBL5402344 0.80 USP36 (0.57) USP36KDM1AMEN1KMT2AHTT
SCHEMBL633339 0.80 MEN1 (0.61) USP36KDM1AMEN1KMT2AHTT
SCHEMBL5401342 0.80 USP36 (0.54) USP36KDM1AMEN1KMT2AHTT
SCHEMBL5831119 0.78 KDM1A (0.54) USP36KDM1AMEN1KMT2AHTT
SCHEMBL5831270 0.77 USP36 (0.62) USP36MEN1KMT2ALMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2007-03-22 US claimed
US-7173030-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2007-02-06 US claimed
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2005-01-13 US claimed
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2007-03-22 US disclosed
US-7173030-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2007-02-06 US disclosed
EP-1631558-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2006-03-08 EP disclosed
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2005-01-13 US disclosed
WO-2004103980-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2004-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD11B2 USP36 2316/4885KDM1A 1429/4885MEN1 942/4885
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD17B11 USP36 2566/4885KDM1A 1457/4885MEN1 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.